The syncytiotrophoblast (ST) is one of the major components of the human placenta, as it is involved in feto-maternal exchanges and the secretion of pregnancy-specific hormones. The aim of this study was to elucidate the formation and function of the ST in trisomy 21 (Down's syndrome). We first used the in vitro model of cytotrophoblast differentiation into ST. Cytotrophoblasts were isolated from 15 trisomy 21-affected placentas (12-35 weeks gestation) and 10 gestational age-matched control placentas. In vitro cytotrophoblasts isolated from normal placenta fused to form the ST. This was associated with an increase in transcript levels and in the secretion of hCG, human placental lactogen, placental GH, and leptin. In trisomy 21affected placentas, we observed a defect (or a delay) in ST formation and a dramatic decrease in the synthesis and secretion of these hormones compared to those in cultured cells isolated from control agematched placentas. These results were confirmed by a significant (P Ͻ 0.001) decrease in gene expression in total homogenates of trisomy 21-affected placentas compared to controls. These results will be of help in understanding the maternal hormonal markers of fetal trisomy 21 and the consequences of placental defects for fetal develop-
T RISOMY OF chromosome 21 (T21), which causes the phenotype known as Down's syndrome, is the major known genetic cause of mental retardation and is found in approximately 1 in 800 live births. Screening strategies to identify women at increased risk of bearing a T21 fetus are based on maternal age, ultrasound signs (1, 2) , or maternal serum markers (3) (4) (5) (6) . Some of these markers, such as hCG (4 -6) , are of placental origin. It is not known why maternal serum hCG is elevated in T21-affected pregnancies.
In human placenta, the syncytiotrophoblast, which forms the outer layer of the chorionic villi, is an active endocrine unit and secretes its hormonal products into the maternal circulation. Some of these polypeptide hormones are specific to pregnancy, such as hCG, human placental lactogen (hPL), and placental GH (PGH) (7) (8) (9) , and can be used as markers of syncytium formation. The syncytiotrophoblast arises in vitro (10, 11) and in vivo (12) from differentiation of villous cytotrophoblasts. These cells aggregate and fuse to form multinucleated syncytiotrophoblasts. The morphological and functional differentiation of cytotrophoblasts into syncytiotrophoblasts can be induced or inhibited by different factors, such as cAMP (13) , growth factors such as epidermal growth factor (14) and transforming growth factor-␤ (15) , polypeptide or steroid hormones such as hCG (16, 17) and dexamethasone (18) , and oxygen tension (19, 20) . Despite the fact that some maternal serum markers of fetal T21 are of placental origin, little is known of placental defects in Down's syndrome. Therefore, the aim of this work was to study trophoblast differentiation and endocrine functions in Down's syndrome.
Materials and Methods

Placental tissue collection
French law allows termination of pregnancy with no gestational age limit when severe fetal abnormalities are observed. Samples of placental tissues were collected at the time of termination of pregnancy at 12-35 weeks gestation (expressed in weeks of amenorrhea) in T21-affected pregnancies and gestational age-matched control cases. Details of the history of all T21 and control cases are given in Table 1 . Gestational age was confirmed by ultrasound measurement of crown-rump length at 8 -12 weeks gestation. Fetal Down's syndrome was diagnosed by karyotyping amniotic fluid cells, chorionic villi, or fetal blood cells. We checked that placental tissue was T21 affected by determination of DNA polymorphism markers (21) . In no case was T21 due to translocation, and no mosaicism was observed. Termination of pregnancy was performed in control cases affected by severe bilateral or low obstructive uropathy or major cardiac abnormalities. Fetal karyotype was normal in all controls. Placental samples were used for cytotrophoblast isolation or were immediately frozen in liquid nitrogen.
RNA isolation and analysis
Total RNA was extracted from frozen placental samples by means of the single step guanidinium-phenol-chloroform method described by Chomczynski and Sacchi (22) and from cultured cells following the procedure of QIAGEN (Courtabeuf, France). The total RNA concentration was determined at 260 nm, and its integrity was monitored by 1% agarose gel electrophoresis. Relative messenger RNA (mRNA) levels of the different genes were measured with the TaqMan 5Ј nuclease fluorogenic quantitative PCR assay essentially as previously described (23) . The nucleotide sequences of the primers and probes are listed in Table  2 . Each sample was analyzed in duplicate, and a calibration curve was run in parallel for each analysis. The levels of transcripts of the constitutive housekeeping gene product cyclophilin A were quantitatively measured in each sample to control for sample to sample differences in RNA concentration and quality. The PCR data are thus reported as the number of transcripts per number of cyclophilin A molecules.
Cell culture
Villous tissue was dissected free of membranes, rinsed, and minced in Ca 2ϩ -and Mg 2ϩ -free Hanks' Balanced Salt Solution. Cytotrophoblasts were isolated after trypsin-deoxyribonuclease digestion and discontinuous Percoll gradient fractionation, using a slight modification of the method of Kliman and Alsat (10, 11) adapted for second trimester placentas. The villous sample was submitted to sequential enzymatic digestions, in a solution containing 0.5% powdered trypsin (wt/vol; Difco, Detroit, MI), 5 IU/mL deoxyribonuclease I, 25 mmol/L HEPES, 4.2 mmol/L MgSO 4 , and 1% (wt/vol) penicillin/streptomycin (Biochemical Industry, Kibbutz Beit Haemek, Israel) in Hanks' Balanced Salt Solution and monitored under light microscopy. The first and/or second digestion were discarded after light microscopy analysis to eliminate syncytiotrophoblast fragments, and the following four or five sequential digestions were kept. The cells collected during these last digestions were purified on a discontinuous gradient of Percoll (5-70% in 5% steps). The cells that migrated to the middle layer (density, 1.048 -1.062 g/mL) were plated on culture dishes (10 6 cells/cm 2 ), attached to the dishes, and 3 h after plating were carefully washed by three washes with culture medium. After this procedure, we checked that at 3 h of culture, 90 -95% of the cells isolated from normal or T21 placentas were cytokeratin 7 positive using a specific monoclonal antibody (dilution, 1:200; DAKO Corp., Trappes, France), less than 0.5% were vimentin positive (dilution, 1:200; Amersham International, Aylesbury, UK), and the other cells were mononucleated and identified as macrophages. None of these cells was hPL positive using a polyclonal specific antibody (dilution, 1:500; DAKO Corp.). Cells were plated in triplicate either on glass slides for immunocytochemistry or onto 60-mm culture dishes (10 6 cells/cm 2 ). They were cultured for 3 days as previously described (11) .
Cell staining
To detect desmoplakin, E-cadherin, cytokeratin 7, or hPL, cultured cells were rinsed with phosphate-buffered saline, fixed, and permeabilized in methanol at Ϫ20 C for 25 min. A monoclonal antidesmoplakin or E-cadherin antibody (1:400; Sigma, St. Quentin Fallavier, France) or anti-hPL (1:500; DAKO Corp.) or a polyclonal anticytokeratin 7 (1:200; DAKO Corp.) was then applied, followed by fluorescein isothiocyanatelabeled goat antimouse Ig (Sigma), as previously described (19) .
Immunoblotting
To detect hPL, cell extracts were prepared as previously described (19) , solubilized protein (5 g) was immunoblotted using a rabbit polyclonal antibody against hPL (1:250; DAKO Corp.), and the specific band was revealed by chemiluminescence (Supersignal Interchim, Pierce Chemical Co., Bezons, France) after incubation with an antirabbit peroxidase-coupled antibody (19) .
Hormone assay
The hCG concentration was determined in culture medium by an enzyme-linked fluorescence assay (Vidas System, BioMerieux, Marcy l'Etoile, France). The assay sensitivity was 2 mU/mL. The hPL concentration was assayed (Amerlex immunoradiometric assay, Amersham Pharmacia Biotech) in maternal serum and in 4-fold concentrated conditioned medium. The assay sensitivity was 0.5 g/mL. Leptin was determined in 4-fold concentrated conditioned medium using the Sen- 
Protein determination
Protein was determined according to Bradford's method (kit from Bio-Rad Laboratories, Inc., Yvry-sur-Seine, France) using BSA as the standard.
Statistical tests
Statistical analysis was performed using the StatView F-4.5 software package (Abacus Concepts, Inc., Berkeley, CA). Values are presented as the mean Ϯ sem. Significant differences were identified using Mann-Whitney analysis; P Ͻ 0.05 was considered significant.
Results
In vitro morphological cytotrophoblast differentiation in T21
Isolated cytotrophoblasts from normal placenta aggregate and fuse in vitro within 48 -72 h to form a syncytiotrophoblast (10, 11, 13) . This is indicated by a gathering of nuclei in a large cytoplasmic mass. In the present study these results were confirmed in 10 different primary cultures of cytotrophoblasts isolated from 10 normal placentas.
In contrast, cytotrophoblasts isolated from 15 different T21-affected placentas had the same plating efficiency as controls and aggregated, but did not fuse or fused poorly. After 3 days of culture, syncytiotrophoblasts were rare, as indicated by immunodetection of desmoplakin (a desmosomal plaque protein; Fig. 1 ) and E-cadherin (a cell adhesion molecule; data not shown). Indeed, desmoplakin and E-cadherin were absent from normal syncytiotrophoblasts as previously shown (19) , but were present at intercellular boundaries in cultured cells isolated from T21-affected placentas. This illustrates a decrease and/or delay in syncytial formation in T21.
Failure of functional differentiation of cultured cytotrophoblasts in T21
In cells isolated from normal placenta, in vitro syncytiotrophoblast formation was associated with large increases in hCG␣ and hCG␤ mRNA (Fig. 2) , hPL mRNA ( Fig. 3) , leptin mRNA, and PGH mRNA (Fig. 4) . Concomitantly, hCG (Fig.  2) , hPL (Fig. 3) , and leptin ( Fig. 4 ) secretion in culture medium increased with time. In cells isolated from T21-affected placentas, the defect in syncytiotrophoblast formation was associated with a clear decrease in hCG␣ and hCG␤ mRNA and hCG secretion in culture medium (Fig. 2 ) compared to those in normal cells. hPL, leptin, and PGH mRNA levels were very low. hPL and leptin secretion could not be detected in culture medium after 3 days. Intracellular hPL was not detected in T21-affected cells, in contrast to normal cells. Because glucose inhibits the secretion of placental GH (24) , this hormone was not assayed in culture medium.
These results suggest that the defect and/or delay in morphological differentiation into syncytiotrophoblast of cytotrophoblasts isolated from T21 placenta was associated with a decrease in both the expression and secretion of hormones specifically synthesized in the syncytiotrophoblast. . Positive immunofluorescence staining is only observed in cytotrophoblasts that are in contact with the syncytiotrophoblast; staining has disappeared in the fused syncytiotrophoblast. In cells isolated from T21-affected placenta, desmoplakin staining is observed at the boundaries between aggregated cytotrophoblasts. Magnification, ϫ2200.
mRNA expression of syncytiotrophoblast hormonal markers in normal and T21-affected placentas
To confirm these in vitro data, we compared, in total homogenates of eight T21-affected placentas and eight gestational age-matched controls (12-35 weeks gestation), transcript levels of these hormones specifically expressed in the syncytiotrophoblast. As shown in Fig. 5 , although levels of the five transcripts varied greatly from one normal placenta to another, the expression of these five genes was significantly lower in T21-affected placentas. Placental samples were homogeneous, as no significant differences vs. controls were noted in cytokeratin 7 mRNA (specifically expressed in the epithelial component of the chorionic villi, i.e. the cytosyncytiotrophoblast), in pleiotropin (trophoblastic growth factor), or in ␤ 2 -microglobulin levels (ubiquitous gene; Fig.  6 ). These results suggest a decrease in functional syncytiotrophoblast mass in T21-affected placenta.
hPL levels in maternal circulation in T21-affected pregnancy
During pregnancy, massive amounts of hPL are synthesized by the syncytiotrophoblast and secreted directly into the maternal circulation (8) . We therefore checked whether the defect in functional syncytiotrophoblasts in T21-affected placentas was associated with a decreased level of hPL in the maternal circulation. As shown in Fig. 7 , we confirmed that hPL levels were lower in pregnancies with fetal T21 from 14 -26 weeks gestation.
Discussion
The human placenta is hemomonochorial and is specific in its structure and endocrine functions. One of its major com-ponents is the syncytiotrophoblast, at the surface of the chorionic villi, which bathes directly in maternal blood which arrives in the intervillous space through the uterine spiral arteries. The highly polarized syncytiotrophoblast secretes its hormonal products into the maternal circulation with almost no storage capacity. Any alteration in syncytiotrophoblast formation and/or function should therefore be reflected in the maternal circulation by changes in the levels of syncytiotrophoblast-secreted hormones.
In the present study we checked that the fetus and placenta were both T21 affected. Cytotrophoblasts isolated from normal and T21-affected placentas were cultured. We confirmed that in vitro normal cytotrophoblasts aggregate and fuse to form the syncytiotrophoblast (10, 11) . This syncytiotrophoblast formation was associated with an increased secretion in culture medium of hCG (7) , hPL (8), PGH (9), and leptin (25) as previously shown. We demonstrate in this study that transcript levels of these hormones also increased with cytotrophoblast differentiation. In T21, cytotrophoblasts adhered to culture dishes and aggregated but did not fuse (or fused poorly), as observed by light microscopy, confirming the preliminary observations of Eldar-Geva et al. (26) and as demonstrated here by the expression of E-cadherin and desmoplakin. These results are in agreement with previous mac- roscopic and histological observations of T21-affected placentas that reveal delayed maturation of chorionic villi and syncytiotrophoblastic hypoplasia with a resistant cytotrophoblastic layer in the third trimester (27, 28) .
This decrease in the syncytiotrophoblast functional mass in T21 placentas is further suggested by the results obtained in homogenates of placental tissues. Indeed, we measured concomitantly by real-time quantitative RT-PCR the expression of the five hormonal genes specifically expressed in the syncytiotrophoblast and encoding hormones secreted in the maternal circulation. In normal placenta, a large variation in mRNA expression of syncytiotrophoblast hormones was observed despite the fact that our sampling was homogeneous, as confirmed by cytokeratin 7, pleiotropin, and ␤ 2 -microglobulin expression levels. Despite these variations, mRNA expression of hormones (hCG␤, hCG␣, hPL, PGH, and leptin) specifically expressed in the syncytiotrophoblast decreased significantly in T21-affected placentas.
In this study we have demonstrated for the first time that in T21-affected placenta there is a defect and/or delay in the formation of the syncytiotrophoblast associated with a decrease in hPL, hCG, PGH, and leptin expression and production. These results do not agree with the previous study by Eldar-Geva (26) , which reported an increase in hCG␣ and hCG␤ mRNA in trophoblast cells of a T21-affected placenta. This discrepancy may be explained by two facts: 1) Eldar-Geva's study was based on the comparison of one normal and one T21-affected placenta that were not gestational age matched; and 2) the cytotrophoblasts in culture may have been contaminated by fragments of syncytiotrophoblast (29) , as hCG secretion diminished instead of increased with time in culture. It is crucial to carefully monitor the isolation and purification of cytotrophoblasts to avoid contamination by syncytiotrophoblast fragments. Our method including sequential enzymatic digestion, Percoll gradient purification, and careful washing of the cells attached to the dish circumvents this problem. Failure to immunodetect hPL in the plated isolated cells unambiguously excludes contamination by syncytiotrophoblast fragments. As anticipated by the results of our in vitro studies, we demonstrated low maternal serum hPL levels in T21-affected pregnancies. Changes in hPL levels during gestation showed that the difference between controls and T21-affected pregnancies was not significant between 15 and 18 weeks. This difference became clearer at 19 weeks and increased up to 24 weeks. This trend paralleled the increase in syncytiotrophoblast mass. These results explain why Ryall et al. observed no differences in maternal serum hPL between 15 and 18 weeks in 48 cases of T21 (30) . In contrast to the results of our in vitro studies, maternal hCG levels are elevated in T21-affected pregnancies (5, 6, 31) . Our study demonstrates a decrease in the synthesis and secretion of hCG in cultured cells from 10 T21-affected placentas as well as a decrease in hCG transcripts in 8 total placenta extracts in T21. How can we explain this paradox? Maternal levels of hormones of syncytiotrophoblastic origin can be related to transcription as well as to the posttranslational process, which may modify hormonal stability. hCG is a complex of two glycosylated subunits. In T21, hCG may be subject to posttranscriptional changes, as suggested by Brizot et al. (32, 33) and recently confirmed by reports of a hyperglycosylated form of hCG in Down's syndrome (34, 35) . This hyperglycosylated form may have a different half-life, thus explaining elevated maternal levels. In contrast, hPL is not glycosylated, and the decrease in its synthesis and secretion was directly reflected by a decreased level in the maternal serum after 19 weeks gestation.
In conclusion, we have demonstrated that 1) there is an abnormal formation of the syncytiotrophoblast in Down's syndrome; 2) there is therefore a decrease in the production of pregnancy-specific polypeptide hormones by the placenta in Down's syndrome. This finding will enhance understanding of the maternal hormonal changes of placental origin that are used as markers of fetal Down's syndrome and will be of help in finding new markers of placental origin. The syncytiotrophoblast plays a key functional role during pregnancy. Better knowledge of its alterations in T21 may therefore be useful in understanding some aspects of fetal development in Down's syndrome.
